In the tumor, almost 20% of the DiD+ (Cy5+) population resembled M-MDSCs in regards to cell surface receptor expression (CD11b/Ly6Chi/Ly6G-), with Ly6G expression mostly absent. This evidence concerns the gene CD177 and neoplasm.